Shingles (Herpes Zoster) Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
Conditions: Rheumatoid Arthritis; Spondylitis, Ankylosing; Spondyloarthritis; Systemic Lupus Erythematosus; Sjogren's Syndrome; Systemic Sclerosis; Idiopathic Inflammatory Myopathies; Vasculitis, Systemic; Juvenile Idiopathic Arthritis; Dermatomyositis, Juvenile Interventions: Biological: Recombinant Herpes Zoster Vaccine (RZV); Other: MTX Discontinuation; Other: MMF Discontinuation; Other: Placebo; Other: MTX maintain; Other: MMF maintain Sponsors: University of Sao Paulo General Hospital; GlaxoSmithKline Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 30, 2023 Category: Research Source Type: clinical trials
A First-in-Human Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
Conditions: Herpes Zoster (HZ); Shingles; Infectious Disease Interventions: Biological: JCXH-105; Biological: Active Control (Shingrix) Sponsors: Immorna Biotherapeutics, Inc.; ICON plc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2023 Category: Research Source Type: clinical trials